Evaluation of fourth international standard for whole cell pertussis vaccine.
Whole cell pertussis vaccine is still widely used in many countries. An International Standard is needed for its potency control. The Third International Standard for Pertussis Vaccine was prepared about 40 years ago and its replacement was recommended by the Expert Committee for Biological Standardisation (ECBS) of the WHO. Material in ampoules coded 94/532 was prepared as a candidate replacement and has been evaluated in international collaborative studies which consisted of two parts. The first part, to assess the suitability of the candidate standard by comparing it with the Second International Standard for Pertussis Vaccine (IS2) involved 14 laboratories in 11 countries. The second part to compare the candidate standard with the Third International Standard for Pertussis Vaccine (IS3) involved 16 laboratories in 14 countries. Since 1995 various other studies have included the international standards and the results of these are also considered in assessing likely continuity of the IU for potency of whole cell pertussis vaccine. The preparation in ampoules coded 94/532 was adopted by the WHO ECBS in October 2006 as the 4th International Standard for whole cell pertussis vaccine and assigned an activity of 40 IU per ampoule on the basis of the studies reported here.
Das
R Gaines
RG
Division of Bacteriology, National Institute for Biological Standards and Control, Health Protection Agency, Potters Bar, Hertfordshire EN6 3QG, UK.
Newland
P
P
Asokanathan
C
C
Douglas-Bardsley
A
A
Corbel
M
M
Xing
D
D
D006801:Humans; D010567:Pertussis Vaccine / Q000592:standards*
D010567:Pertussis Vaccine